Viewing Study NCT06805812


Ignite Creation Date: 2025-12-26 @ 10:17 PM
Ignite Modification Date: 2025-12-31 @ 5:13 AM
Study NCT ID: NCT06805812
Status: RECRUITING
Last Update Posted: 2025-02-03
First Post: 2025-01-07
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Predicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advanced Hormone REceptor-poSitive HER2-negative Breast Cancer: the Retrospective-prospective Multicenter Italian PALMARES-2 Study
Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module